Surgical Soft Tissue Forceps Market Report 2026

Surgical Soft Tissue Forceps Market Overview

• Surgical Soft Tissue Forceps market size has reached to $1.38 billion in 2025 • Expected to grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: The Rise In Aesthetic Procedure Volumes Fueling Market Growth Due To Increasing Demand For Cosmetic Enhancements • North America was the largest region in 2025.

What Is Covered Under Surgical Soft Tissue Forceps Market?

Surgical soft tissue forceps are specialized instruments used in surgical procedures to grasp, hold, and manipulate soft tissues without causing significant damage. They are designed with fine tips and a gentle grip to handle delicate tissues carefully. The main types of surgical soft tissue forceps are disposable and reusable. Disposable refers to surgical instruments intended for single use only, typically made from materials designed to be cost-effective yet functional for a single procedure, where hygiene and contamination risk are critical concerns, such as in sterile environments or surgeries involving infectious diseases. The applications include hospital, clinic, and others, and end users include gynecology, general surgery, neurosurgery, plastic surgery, and others.

What Is The Surgical Soft Tissue Forceps Market Growth Forecast?

The surgical soft tissue forceps market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for disposable surgical instruments, rising focus on infection prevention, expansion of outpatient surgical procedures, growing adoption of advanced material coatings, increasing healthcare spending on surgical tools. Major trends in the forecast period include increasing demand for precision surgical instruments, rising adoption of single-use surgical forceps, growing focus on ergonomic instrument design, expansion of corrosion-resistant forceps materials, enhanced emphasis on sterility and infection control.

What Are The Drivers Of The Surgical Soft Tissue Forceps Market?

The rising number of aesthetic procedures performed is expected to propel the growth of the surgical soft tissue forceps market going forward. Aesthetic procedures are elective medical treatments, both surgical and non-surgical, aimed at enhancing or improving an individual's physical appearance. The rise in these procedures is driven by evolving beauty standards, greater accessibility to cosmetic treatments, and the influence of social media trends that emphasize appearance enhancement. Surgical soft tissue forceps are essential in aesthetic surgeries as they allow surgeons to precisely handle delicate tissues, minimize trauma, and ensure accurate placement during procedures such as facelifts, rhinoplasties, and breast augmentations. For instance, in June 2025, the International Society of Aesthetic Plastic Surgery Inc., a USA-based nonprofit organization, published its 2024 Global Survey, reporting 17.4 million surgical aesthetic procedures and 20.5 million non-surgical aesthetic procedures performed worldwide in 2024, totaling nearly 38 million procedures, aesthetic procedures close to 38 million in 2024. Therefore, the rising number of aesthetic procedures is driving the growth of the surgical soft tissue forceps industry. The rise in the preference for minimally invasive surgeries is expected to propel the growth of the surgical soft tissue forceps market going forward. Minimally invasive surgeries are medical procedures that involve small incisions, often using specialized instruments and imaging techniques to minimize tissue damage. The minimally invasive surgeries are fueled by factors such as quicker recovery times, shorter hospital stays, reduced postoperative pain, and a lower risk of complications compared to traditional open surgeries. surgical soft tissue forceps aid in surgeries by allowing precise removal of abnormal tissues, such as polyps or tumors, through small incisions. Their design enables adequate tissue resection with minimal damage to surrounding structures, enhancing the overall effectiveness and safety of the procedure. For instance, in June 2024, according to the data published by the American Society Of Plastic Surgeons, a US-based professional society representing plastic surgeons, there was a 7% rise in minimally invasive procedures from 2022 to 2023 in the USA. Therefore, increasing the preference for minimally invasive surgeries will drive the surgical soft tissue forceps industry.

Key Players In The Global Surgical Soft Tissue Forceps Market

Major companies operating in the surgical soft tissue forceps market are Medtronic plc, Johnson & Johnson MedTech, Medline Industries, Stryker Corporation, B. Braun Melsungen AG, Olympus Corporation, CooperSurgical Inc., Cook Medical, Karl Storz GmbH And Co. KG, Integra LifeSciences Corporation, ConMed Corporation, KLS Martin Group, Aesculap Inc., Richard Wolf GmbH, Aspen Surgical Products Inc., Symmetry Surgical Inc., MedGyn Products Inc., Scanlan International Inc., Sklar Surgical Instruments, GPC Medical Ltd., Hayden Medical Inc., Millennium Surgical Corp., S Murray And Co Ltd., Surgmed Group, Lawton GmbH And Co. KG, Marina Medical Instruments Inc., Surgipro Inc., Surtex Instruments Ltd.

What Are Latest Mergers And Acquisitions In The Surgical Soft Tissue Forceps Market?

In January 2024, Stille AB, a Sweden-based company that develops and manufactures surgical instruments, acquired Fehling Instruments GmbH and Co. KG and associated subsidiaries for $40.32 million. This acquisition is to expand Stille AB's portfolio of high-quality medical instruments, particularly in demanding surgical specialties such as open and minimally invasive cardiac, thoracic, neuro, and spine surgery. Fehling Instruments GmbH & Co. KG is a Germany-based surgery instrument manufacturing company, including surgical soft tissue forceps.

What Defines the Surgical Soft Tissue Forceps Market?

The surgical soft tissue forceps market consists of sales of products such as adson forceps, deBakey forceps, bishop-harmon forceps, and brown-adson forceps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Surgical Soft Tissue Forceps Market Report 2026?

The surgical soft tissue forceps market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the surgical soft tissue forceps industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.